Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20038030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048589HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20026706HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048288HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20033039HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20021233HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20032030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44018639HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44021744HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44029331HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB09089
Drug NameTrimebutine
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs8822036
CitationsEglen RM, Watson N: Selective muscarinic receptor agonists and antagonists. Pharmacol Toxicol. 1996 Feb;78(2):59-68.
GroupsApproved
Direct ClassificationGallic acid and derivatives
SMILESCCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL190044